Liliflone



Compound IDCDAMM01742
Common nameLiliflone
IUPAC name2-(4-hydroxy-3-methoxyphenyl)-3a,7a-dimethoxy-3-methyl-5-prop-2-enyl-3,7-dihydro-2H-1-benzofuran-6-one
Molecular formulaC21H26O6

Experimental data

Retention time10.69
Adduct[M+H]+
Actual mz375.183
Theoretical mz375.18
Error6.46
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.0993

Identifiers and class information

Inchi keyZJCOLWRTVHBIBE-GXPHDMAONA-N
SmilesO=C1C(=CC2(OC)C(C)C(OC2(OC)C1)C3=CC=C(O)C(OC)=C3)CC=C
SuperclassBenzenoids
ClassPhenols

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)6
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)374.433
Computed dipole moment(dipole)3.08
Total solvent accessible surface area (SASA)630.042
Hydrophobic component of SASA (FOSA)409.634
Hydrophilic component of SASA (FISA)85.074
Pie component of the SASA (PISA)135.334
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1175.92
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)5.75
Free energy of solvation of dipole (dip^2/V)0.0080674
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0091264
Globularity descriptor (glob)0.855159
Predicted polarizability in cubic angstroms (QPpolrz)38.346
Predicted hexadecane/gas partition coefficient (QPlogPC16)10.941
Predicted octanol/gas partition coefficient (QPlogPoct)16.932
Predicted water/gas partition coefficient (QPlogPw)8.539
Predicted octanol/water partition coefficient (QPlogPo/w)3.841
Predicted aqueous solubility (QPlogS)-4.68
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.104
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.521
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)1545.77
Predicted brain/blood partition coefficient (QPlogBB)-0.574
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)792.122
Predicted skin permeability, log Kp (QPlogKp)-2.035
PM3 calculated ionization potential (IP(ev))8.819
PM3 calculated electron affinity (EA(eV))0.449
Number of likely metabolic reactions (#metab)5
Prediction of binding to human serum albumin (QPlogKhsa)0.45
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)72.967
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P11926ODC1Ornithine decarboxylaseT60366SEA
Q7Z2W7TRPM8Transient receptor potential cation channel subfamily M member 8T41955SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P10636MAPTMicrotubule-associated protein tauT45593SEA
Q9NR20DYRK4Dual-specificity tyrosine-phosphorylation regulated kinase 4T20542SEA
Q8N183NDUFAF2HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2T01453SEA
Q9P0J0NDUFA13Mitochondrial complex IT82391SEA
Q9Y6M9NDUFB9HUMAN NADH:ubiquinone oxidoreductase subunit B9T01465SEA
Q8N183NDUFAF2HUMAN NADH:ubiquinone oxidoreductase complex assembly factor 2T01453SEA
P03897MT-ND3NADH dehydrogenaseT77195SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T41955DI0422Upper respiratory tract disorder[ICD-11: CA0Z]Q7Z2W7TRPM8
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T45593DI0012Acute myeloid leukaemia[ICD-11: 2A60]P10636MAPT
T45593DI0025Alzheimer disease[ICD-11: 8A20]P10636MAPT
T45593DI0265Mild neurocognitive disorder[ICD-11: 6D71]P10636MAPT
T82391DI0069Cardiomyopathy[ICD-11: BC43]Q9P0J0NDUFA13
T77195DI0331Parkinsonism[ICD-11: 8A00]P03897MT-ND3

Copyright © 2025